Application of phased intensive medication education on patients with percutaneous coronary intervention

Objective To evaluate the application effect of phased intensive medication education (PIME) on patients after percutaneous coronary intervention (PCI) . Methods By convenience sampling method, 60 patients who underwent PCI for the first time in Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College from October 2017 to February 2018 were selected and randomly divided into experimental group (n=30) and control group (n=30) . The experimental group was educated by PIME, while the control group received conventional medication education. The patients were followed up after discharge. Seven indicators, including medication literacy, medication compliance and exercise tolerance and so on were collected and compared. Results There was no significant difference in the scores of medication literacy between the two groups before intervention (P>0.05) . On the day of discharge, 1 month and 3 months after discharge, the scores of the experimental group were higher than those of the control group, and the differences were statistically significant (P 0.05) . At 2 weeks, 1 month and 3 months after discharge, the scores in the experimental group were higher than those in the control group with statistical differences (P 0.05) . The experimental group was higher than the control group at 3 months after discharge with a statistical difference (P<0.01) . The decrease of heart rate and systolic blood pressure in the experimental group was greater than that in the control group (P<0.05) . One month after discharge, the incidence of adverse medication reactions in the experimental group was lower than that in the control group and the difference was statistically significant (P<0.05) . Conclusions PIME can effectively improve patients' medication literacy, medication adherence, safety and effectiveness, which is worthy of promotion. Key words: Phased educational approach; Ebbinghaus memory method; Medication education; PCI